Tuesday July 8 3:55 PM EDT
Company Press Release
Source: MedCare Technologies, Inc.
MedCare Technologies Expands Management Team With New
Chief Operating Officer and President
NAPERVILLE, Ill., July 8 /PRNewswire/ -- MedCare Technologies, Inc. (OTC Bulletin Board: MCAR)) today
announced the appointment of Mr. Jeff Aronin as Director, President and Chief Operating Officer. Mr. Aronin has
extensive experience in the healthcare industry, with particular expertise in corporate development, sales and sales
management, healthcare marketing, and managed healthcare. During his six years at a Fortune 500 pharmaceutical
company and two years at a fast growing healthcare manufacturer, Mr. Aronin has held various sales and management
positions. During his tenure, divisional revenues increased by 126% and 50% respectively. Mr. Aronin has an MBA
from Northwestern University, Kellogg School of Business and a Bachelor of Science from Northern Illinois
University. ``We are very pleased to have Mr. Aronin join the Company,'' said Harmel S. Rayat, Chairman and CEO
of MedCare Technologies. ``He has a solid background in healthcare and has established himself as a results-oriented,
proven achiever. We believe that Mr. Aronin has the requisite skills and experience to greatly enhance our corporate
growth in the future. This growth will include HMO's, PPO's physician practices, hospital outpatient clinics, assisted
living facilities, nursing homes and international possibilities.''
MedCare Technologies has developed a cost effective, non-drug, non- surgical and non-invasive system for the care
and treatment of patents suffering from urinary incontinence. MedCare's treatment protocol does not require FDA
approval, is covered by most health insurance plans and results in the reduction or complete elimination of 70% to
100% of the most commonly found urinary incontinence symptoms. Unlike traditional treatment options, which are
costly and often unsuccessful or inadequate, MedCare's proprietary treatment program is completely risk free and has a
three year history with a proven success rate in excess of 85%. MedCare Technologies offers a multi- modality
program based on behavioral techniques and neuromuscular electromyography biofeedback. The MedCare Program is
designed to mobilize and strengthen various sensory-response systems and is based on operant conditioning strategies
whereby specific physiological responses are progressively shaped, strengthened and coordinated.
Numerous studies have been completed to determine the prevalence of urinary incontinence in the general population.
The results of one study completed at Emory University in Atlanta, GA, concluded that the prevalence of UI was
43.6% among women and 20.9% among men, in another study of 3,638 patients over age 20, 1908 women and 922
men completed an anonymous questionnaire. A reported 43% of women and 11% of men had current UI. Almost 75%
of these patients had not informed a health professional, but more than one-third of these said they would see a
physician if treatment were available. Affecting some 25 million Americans, UI is a $16 billion market and accounts for
almost half of all nursing home admissions. Despite being one of the most prevalent medical conditions in health care
today, with almost half of all women being affected at some point, UI remains a vastly underserviced and over-looked
market place.
For additional information, please contact Mr. Bill Mann at 800-611-3388.
SOURCE: MedCare Technologies, Inc.
Contact: Bill Mann for MedCare Technologies, Inc., 800-611-3388 |
